Delivery Order SPE2DB20D7061-SPE2DB25FSLX5
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.15 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 MG CAPSULE 30S, a generic medication. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award, valued at $1,035.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564675659 ! ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,328.32, is for the delivery of ATOMOXETINE 25MG 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FREK7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,431.89, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,315.00, is a Firm Fixed Price Delivery Order for the supply of ATOMOXETINE HCL 18 30S medical products. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award, valued at $1,454.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a medication used to treat certain mental health conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 25, 2024. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $1,292.40 fixed-price delivery order is for the supply of 4564350703 - ATOMOXETINE HCL 40 MG CAPSULE 30S, with a completion date of April 23, 2024. Amerisourcebergen holds two larger Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...